Numerous clinical trials are always open and enrolling patients in the ECOG-ACRIN Cancer Research Group, which focuses its research on adults 18 years of age and older who have or are at risk of developing cancer. This section of the website contains all educational materials that are publicly available to patients and researchers.

To access educational materials for a particular trial, click on the trial ID in the list below.

Cancer Type

Trial ID and Target Patient Population
Any Solid Tumor, Lymphoma, or Myeloma, or Cancer Type with No Standard Treatment Available NCI-MATCH / EAY131 – Eligibility Based on Genetic Testing
Brain EAF151 – Recurrent Glioblastoma
Breast EA1131 – Triple-Negative (Including Men)
EA1151 aka TMIST – Breast Cancer Screening
EAI142 – Newly Diagnosed, Advanced
6694 – Imaging of Women in the Alliance A011104 Trial
Cancer Care Delivery Research EAQ161CD – Assessment of Biomarker Testing Practices
EAQ162CD – Assessment of Financial Burden, Colon/Rectal
EAQ171CD – Implementing Virtual Tobacco Treatment
Cancer Control EA9131 – Acute Promyelocytic Leukemia (APL)
and Survivorship E1Q11 aka EROS – Reproductive Health Planning
Gastrointestinal EA2142 – Pancreas or Gastrointestinal Tract, Advanced
EA2161 – Pancreas
EA2165 – Anal
EA2174 – Logoregional Esophageal and Gastroesophageal Junction Adenocarcinoma
7151 – Detection of Colon Cancer (By Invitation Only)
Genitourinary EA8134 aka InPACT – Penis
EA8143 aka PROSPER RCC – Kidney
EA8153 aka CHAARTED2 – Hormone-sensitive Prostate
EA8171 – Newly-Diagnosed Prostate (Imaging)
Gynecologic EAE161 – Ovarian, Fallopian Tube, or Peritoneum
Head and Neck EA3132 – p53 Mutated  Squamous Cell, Removed by Surgery
EA3161 – Locally Advanced, Intermediate Risk HPV Positive Oropharynx Cancer
EA3163 – Nasal and Paranasal Sinus Squamous Cell Carcinoma
Leukemia EA9152 – T-cell or B-cell Acute Lymphoblastic Leukemia (ALL)
EA9161 – Chronic Lymphocytic Leukemia (CLL) in Patients Aged 18-70 Years
EA9171 – Myeloid Leukemia
NHLBI-MDS aka The National MDS Study – Observation of Myelodysplastic Syndromes (MDS)
Lymphoma EA4151 – Mantle Cell
EA4181 – Mantle Cell
E4412 – Hodgkin
Melanoma EA6134 – Advanced, BRAFV600 Mutated
EA6141 – Advanced
EA6174 aka STAMP – Resected Merkel Cell Carcinoma
Myeloma EAA172 – Relapsed/Refractory
EAA173 aka DETER-SMM – Smoldering Myeloma
Prevention EAZ171 – Peripheral Neuropathy in African American Women
Thoracic EA5163 aka S1709 aka INSIGNA – Advanced NSCLC
E4512, an ALCHEMIST treatment trial – Early, Non-Squamous, Non-Small Cell Lung, Removed by Surgery
4703 aka DECAMP-1 – Detection of Early Lung Cancer in Military Personnel
4704 aka DECAMP-2 – Screening of Military Personnel with Early Stage Lung Cancer or at High Risk of Developing Lung Cancer
6697 – Imaging Substudy for Patients in the RTOG 1106 Trial
2091
Resources
Group Meetings
Resources for Active Trials
NCI-MATCH / EAY131 for Researchers
ECOG Performance Status
Publications
CIRB
Medidata Rave®
TRIAD™
SOAPP
PrECOG
Related Websites
Document Library